S&P 500 7,757.17 +0.58%
Nasdaq 26,702.86 +1.05%
S&P/TSX 36,324.99 +0.60%
Apple 343.99 +1.32%
Nvidia 221.97 +2.54%
Microsoft 532.95 +0.20%
Shopify 244.93 +0.38%
Royal Bank 283.62 +1.23%
CAD/USD 0.7120 +0.15%
CLOSED · 21:40 ET
Market ClerkRecap
Wed Oct 21 · markets closed2 signals today78 insider buys this week · $240.8MCIRO short report next: Oct 31The week ahead
SL
INSIDER · ORKA · Oruka Therapeutics, Inc. · CHIEF OPERATING OFFICER

Sandler Laura Lee

Every open-market transaction filed under this name, Sep 1 to Sep 15.

Filings
3
0 buys · 3 sells
Bought
—
open market, at cost
Sold
$546K
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Sep 15ORKAOruka Therapeutics, Inc.Chief Operating OfficerSell906$95.71$87K−16.5%
Sep 1ORKAOruka Therapeutics, Inc.Chief Operating OfficerSell4,000$92.01$368K−13.1%
Sep 1ORKAOruka Therapeutics, Inc.Chief Operating OfficerSell1,000$91.05$91K−12.2%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.